Showing results (291-300 of 339) with videos related to

Sort By:
Pageof 34
BMC Cancer|June 2, 2019
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world dataJun Sik Yoon, Byeong Geun Song, Jeong-Hoon Lee, et al.
Plos One|November 16, 2016
Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus BYuri Cho, Dong Hyun Sinn, Su Jong Yu, et al.
Plos One|August 1, 2012
Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patientsMin-Sun Kwak, Dong Hyeon Lee, Yuri Cho, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 1, 2024
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort studyHyunjae Shin, Seung Up Kim, Byeong Geun Song, et al.
Journal of Proteome Research|January 24, 2017
Targeted Proteomics Predicts a Sustained Complete-Response after Transarterial Chemoembolization and Clinical Outcomes in Patients with Hepatocellular Carcinoma: A Prospective Cohort StudySu Jong Yu, Hyunsoo Kim, Hophil Min, et al.
Gut and Liver|January 8, 2025
A Novel Point-of-Care Prediction Model for Steatotic Liver Disease: Expected Role of Mass Screening in the Global Obesity CrisisJeayeon Park, Goh Eun Chung, Yoosoo Chang, et al.
British Journal of Cancer|October 14, 2016
TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trialsDae-Won Lee, Myoung-Jin Jang, Kyung-Hun Lee, et al.
Medicine|September 2, 2016
Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case-control comparative analysisSu Jong Yu, Jung-Hwan Yoon, Jeong Min Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 5, 2019
Additional fibrate treatment in UDCA-refractory PBC patientsSung Won Chung, Jeong-Hoon Lee, Minseok Albert Kim, et al.
The Korean Journal of Internal Medicine|September 18, 2014
A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomeraseSu Jong Yu, Jae-Kyung Won, Han Suk Ryu, et al.
Pageof 34